Last reviewed · How we verify
NCT03477045
Does Consuming Modified Plant Seed Oil Containing Fish Oil Fatty Acids Act in the Same Way as Consuming Fish Oil?
NA trial testing Single dose fish oil in Healthy in 31 participants. Completed in 4 November 2019.
4 November 2019
Quick facts
| Lead sponsor | University of Southampton |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 31 |
| Start date | 9 June 2017 |
| Primary completion | 4 November 2019 |
| Estimated completion | 4 November 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Single dose fish oil
- Repeated dose fish oil
- single dose Camelina seed oil
- repeated dose camelina seed oil
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
University of Southampton
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fish oil and oily fish contain omega 3 long chain polyunsaturated fatty acids known to be beneficial to health. Many people consume little, despite UK government recommendations to eat at least one portion of oily fish per week. Furthermore, despite modest consumption, fish stocks are declining due to over fishing. Therefore, there is a need for an alternative, sustainable and cost efficiently produced dietary source. A seed oil source of these fish oil-type fatty acids has been achieved by adding genes from other plant sources to the oil seed plant Camelina sativa. Camelina sativa, related to mustard and cabbage, has provided seed oil for human consumption for thousands of years. It was the most important oil seed plant in Europe until the 1900's. This research is being done to see if consuming fish oil-type fatty acids in Camelina seed oil allows the body to take up and use the fish oil fatty acids in the same way as it does from fish oil.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review.
Rizzo G, Baroni L, Lombardo M. · · 2023 · cited 33× · PMID 36767052 · DOI 10.3390/ijerph20031683 -
Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans.
West AL, Miles EA, Lillycrop KA, Han L, et al · · 2019 · cited 24× · PMID 30975228 · DOI 10.1017/s0007114519000825 -
Dietary supplementation with seed oil from transgenic <i>Camelina sativa</i> induces similar increments in plasma and erythrocyte DHA and EPA to fish oil in healthy humans.
West AL, Miles EA, Lillycrop KA, Han L, et al · · 2020 · cited 18× · PMID 32513312 · DOI 10.1017/s0007114520002044 -
Lipidomic Analysis of Plasma from Healthy Men and Women Shows Phospholipid Class and Molecular Species Differences between Sexes.
West AL, Michaelson LV, Miles EA, Haslam RP, et al · · 2021 · cited 14× · PMID 33284478 · DOI 10.1002/lipd.12293 -
Dietary Supplementation with Transgenic <i>Camelina sativa</i> Oil Containing 20:5n-3 and 22:6n-3 or Fish Oil Induces Differential Changes in the Transcriptome of CD3<sup>+</sup> T Lymphocytes.
West AL, Miles EA, Han L, Lillycrop KA, et al · · 2021 · cited 2× · PMID 34578993 · DOI 10.3390/nu13093116
Verify or expand the search:
- PubMed search for NCT03477045
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of Southampton trials
Trials by the same sponsor.
- NCT07531277 — Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Prim · NA · not yet recruiting
- NCT06923943 — Predicting Nurse Staffing Requirements From Routinely Collected Data · active not recruiting
- NCT06692959 — A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer · Phase 2 · recruiting
- NCT06815120 — A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent · NA · not yet recruiting
- NCT06566157 — PROMOTE: The Effect of a Six Week Prebiotic Supplementation on Wellbeing of Young Adults. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03477045 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southampton
- Last refreshed: 15 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477045.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing